NFE2L2 and neoplasm: In tumor-associated myeloid-derived suppressor cells (MDSCs), loss of Nrf2 exacerbates the high level of reactive oxygen species (ROS) [24], which promote tumor-mediated immune suppression by inhibiting innate and adaptive immunity [48].